Member Info for year1970

placing to follow, you know why these companies doing presentations for, they look for new investors. It is coming very soon for you. I see some of you very excited with multiple trials happen in parallel, but nothing is cost free, it will require a lot more funds, just pop over to VAL and see for yourself, the sp was fine before clinical trail for val201 and it was not that bad even the trail started but since they started another compound 401 the sp was almost in free fall.

I had been refusing to look at my share dealing account for almost 3 years just to save me me from disappointment with my VAL share but today I decided I had nothing to lose and obviously I could not remember all my login details. After few minutes with the halifax agent over the phone and finally managed to login my account to face the reality so here is the reality:

- Bought years ago with 160890 shares at average costed of 7.9577p per share so total cost was £12,803.21
- Today with the same amount, it is currently valued at 0.59p per share and the current valuation is £949.25

After all those years the total paper lost currently stands at £-11,853.96 which is equivalent to -92.59%. I think I am still very lucky compared to more than half of anyone who is still holding this share. I should celebrate rather than feel sorry for myself...

right I need to go back to work to bring home bread and butter and leave the experts here to guess about this company future...have great day everyone.

I have been a vocal of putting down VAL401 and never thought this compound would be considered to any further clinical trials but today it proved me wrong and I am happy to accept that wrong and it made few posters on the SCLP board not very happy, so be it.

If you have done any research in phase 3 clinical trials then will know this phase is significant and costly too, commercial business has to be considered seriously in this phase. The rns was very clear that there are some companies are interested about taking this compound further and they cannot lie about this, these companies will be revealed soon and it looks like phase 3 is going to happen, good news for the sufferers.

When VAL took a share in VAL401 in April 2014, they owned 60% of the compound and today they owned 55%. So not much of a different, the value can only go up and not down. One important thing is that they are sitting on the board of SEEK, so they will get involve with all discussions. They have helped to bring VAL401 to the completion of phase 2b so they have honoured their responsibilities. It is no surprise to know that any further clinical trials has be funded by a partner and not Valirxs.

What we do not know is what is in the deal, but whatever the deal is one thing we all have to agree is that some companies see potential in VAL401 which a lot of people didn't have any hope including myself. So that is the great news and we need to wait how the deal will pan out, we all know it is happening...

Obelix, U know you for at least 6 years on this board MATE, at the time you told everyone that you were at uni and was planning to study at Harvard in the USA the next year...After that many years and you are now telling everyone again that you are still at uni, if you don't mind then could you leak a little bit what are you doing at the uni MATE??? Hope you are not doing the course "Learn How To Trade In AIM", in that subject you should be a professor by now MATE. Take care MATE.

Also if VAL or SCLP had that kind of funding like SAR is enjoying then the sp of these two companies would not be that bad but it is history now.

CEREUS, not sure what the issue you have with Sareum (SAR)... I don't invest or trade in that share but in the last 5-7 years SAR is the best performing share compared to VAL or SCLP. They have lost little in value so you should be happy with that.

I hope so too Knowlesi. This board have bunch of bullies and posting the same thing over and over again for years, it bored me to read but your posts in the last few days certainly light up this board. Why these guys think that a commercial deal is around the corner or next year is beyond me, if they are lucky then maybe another 2 years or still no deal, don't forget SCLP will always tell they are discussing commercial deals all the time, VAL bod keep telling people the same thing for years. There is nothing wrong with that, at the end they need to knock on people door and also don't forget big boys/girls are fully aware of what SCLP doing, they look for opportunities all the time. I said before that this share will be under 5p and that is the way it will head to. Obviously there will be ups and downs along the way.

What you said Yesterday was a very good point, if they think they need money in near future and there might not be a chance to raise the sp any higher then now is a good time to raise rather than wait until later when the sp is not the same and much lower. The reason I mention this because I used to invest in VAL and at one point not long ago it was around 20-60p for long time but they didn't raise fund and when the sp was really low then they stated to raise like hell which obviously made the sp a lot worst. Unless they have confident to turn the sp in a better shape before raise fund again otherwise they will make a lot of people upset. Have a great day.

You asked a simple question and these two posters chelseas7 and inanaco just confused you, they keep trying to convince people they know everything. If you have been in AIM market long enough then it would be a waste of time to ask that question because this market has very high risk but very minimal return, majority of people who invested in this market do not make any money, believe me or not but most are in red, only a very very small group of traders and lucky investors who actually make anything.

This market is all about sentiment, when it is with the share, 20-30-50-100-200% increase in 1-2 days/weeks is normal without any news, bulls just arrive and buy in with no obvious reason and nothing can stop, all just rumour and hope, but at some point they will realise it was over-bought or trader sell and nothing happen then slowly the sp will drop. That was exactly with VAL few weeks ago.

In this market you have to TRADE, put in STOP loss and consider to sell some if you make 20-30% profit. You can trade on any share, all share will go ups and downs, and at the moment in bio sector VAL or SCLP or MTFB....are good candidates for trade.

About VAL, I have no sympathy for anyone who bought in at high a few days/weeks ago and loss 50-70% from the last placing, they were clearly warned. I have no confident in VAL401 and if even by somehow VAL managed to make a deal, I think that deal would be nothing significant, this compound is just a bonus and also don't put any hope in 101 or 301 because those compounds will be a long time, at least 4-5 years before you see anything. Our best bet is VAL201, but it depends on how that span out, even with good result from the clinical trials still no guarantee a deal, just pop over and check sclp on their SCB1 results, it completed years ago but still could not sell. VAL201 has to be outstanding or something exceptional...

Deep down, VAL is the same as any other bio techs, they are trying and we have to accept there will be failures and hurdles here and there, it is not easy, everything takes time and it is even harder with cancer. There are many other companies are trying as well, and don't forget the trials is done by other professionals on patient live, they have no control so they cannot make up. The problem with VAL is solely bad management and it seems over many years they do not learn or maybe as some posters put it, they do not care otherwise the sp won't be this bad...

I have noticed people keep expect some great news in Q1 this year, I am not sure when did VAL promise that or some just made it up??? If GM said that in the presentation then ignore it. The one you should hope for news is the VAL201 trials result which we don't really know when but should not be too long.

Knico56, if you understand the phases of clinical trials and will agree with me the difficulties and significant of passing phase 2b, even without take over or liciensibg it should add millions of £££ to the company value. Here we completed phase 2b with Val401 and our sp actually going negative direction. I said here before that the chance of us selling on val401 is very much zero, the market is not impressed, all Val was hoping for was peer reviews after spending a lot of money, big boys and girls already had accessed to data long before us and they already made up their mind.

Bluepabther, as far as I know Lunatic has been investing and interested in this share for at least 6-7 years. He really have a special attention for this his beloved share.

Regarding Val, you have to accept that the sp cannot do well when they have to fund on their own on various trials at the same time, it would affect any share and not just Val. Big pharmas are more careful in their investment too after many big write off in the past on their early acquisition, it is not that easy like before the financial crashed 2009 any more.

But one thing I have mentioned many times on here before is that this BOD is really bad at their financial decisions, even at the time in the past when the sp was quite strong and they still gave away at least 25% discount price for small placings and they kept raising funds constantly for years. It would have been better if they raised a big amount and less frequent, it would affect the sp a lot less because people don't feel the next one would be just around the corner. But unfortunately, that option is no longer available because the asset value is not big enough to allow that to happen.

Well, it could be MFTB was too honest. The honest could be it knows that it would take long time to work in the form which would be acceptable to FDA or they know it could not be met but pretended to say they would work with FDA. I never follow MFTB so cannot say much but the second worst bit was they publicly said that they would need to raise more money in near future. Obviously that contributed to the huge down turn, it would be better they left that bit out because it has nothing to do with the FDA statement.

Regarding this share SCLP, I don't follow either, the last time I checked the rns before today was when they planned to do phase 2 for scb1 and plase 1 for scb2. At the time the plan was to have some kind of partner on board (cannot remember who but I thought was a good move) but it was not clear who would cover the trials cost, and I must say sclp is very good at finance management. Even considered those two factors I did say on here at the time that I expected the sp to drop below 10p, for now it is under 10p and if I am being honest I do expect this share to drop below 5p at some point. You may get spike here and there especially when get approval from FDA which I have no doubt sclp will get but the trend is that way. I cannot see how scb1 will complete the trials in one year time, realistically it will ta least 2 years...and it has not even started yet. All the best.

As I mentioned sometime before Colin will come up with a cunning plan for XTR soon and the target is to make money at the end of this year or early next year.

Jezzoo, thanks for revealing the rare and positive side of aim trading, could you also list all other truth side too please...lol. BTW, it is very rare anyone making money in aim, very small (tiny) number of traders who make some money and hope you're one of them, majority are in deep the red...

scooby-do, brilliant post and absolutely agreed, some people seems to obsess with this board, need to grow up.

I stop watching VAL presentations until today when someone posted the link so I thought just listen a bit to kill off the time. To be honest after listened to George and if I was the first time investor looking for a company to invest then VAL must be a serious contender, deal is just around the corner and as he said he was very busy flying around...suppose to meetings to discuss who would offer better deals...and it is hard to see how the sp not going north but keep falling.

The problem here is that Satu used to do the same, if anyone has her presentation about 7-8 years ago then would see what I mean, she constantly said she was in discussions with big boys and girls all the time, the funny thing is that in one of her presentations she even giving out advice what to look for when invest your hard earned money in a company. Looks like not many people believe them anymore. The question here is that, do they really care? Personally I don't think so because they know that they will be around for long time, there are still Val 101 and 301 and many more in the pipeline to come...

jonjo. it doesn't matter how bad the share is you can always make profit if you buy and sell at right time, all shares will go ups and downs all the time. I would not take too serious if people say they are topping up...it would not surprise me if VAL go up next week for 50% for some rumour...

jonbhoy, the answer is NO because the trials is done by external consultants but it is up to VAL how they communicate the results back to us but they cannot fiddle with the figures, so from the figures of VAL401 would you be able to tell if it was a success or not???

If anyone tries to understand phases in clinical trials then would agree that there are many trials failed in 2b which is the Val401has just completed, Val201 is only in 2a. I am quite disappointed to say there seems zero reward from the market for the achievement in val401, to me it shows that the market is not impressed with the result and we are confused to and waiting for peer reviews. In reality peer reviews is not that important because big pharms are constantly looking out for opportunities to take the compounds further, they have many experts in their companies and are aware of what small companies doing, I used to work for Glaxowellcome many years and I know it, the peer review is only for public knowledge, experts already had access to data and made decisions long before that. Personally, I am looking forward to val201, the 2a clinical trials have costed us a lot of money compared to val401. Don't take all the talks in the presentation too serious, they are trying to get new investors so everything has to be rosy in the near future. Have great day everyone.

The main purpose of presentation is to get new investors to invest into the company, if the deal is that great or it is very near then the company do not need new investors because bulls will arrive in huge numbers if there is a good news. So now when I hear a presentation coming I know what would happen next...

BTW, you will always hear all the good/positive things in the presentation, nothing is bad otherwise there is no point, also it is very unlikely you will learn anything new. All new things must release through rns